These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32359702)

  • 1. Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial.
    Afferi L; Moschini M; Mattei A; Montorsi F; Briganti A; Cathelineau X; Sanchez-Salas R
    Eur Urol; 2020 Aug; 78(2):289-290. PubMed ID: 32359702
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial.
    Kuusk T; Bex A
    Eur Urol; 2020 Oct; 78(4):630-631. PubMed ID: 32451179
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial.
    D'Andrea D; Pradere B; Shariat SF
    Eur Urol; 2021 Jan; 79(1):163-164. PubMed ID: 32981804
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Alison Birtle, Mark Johnson, John Chester, et al. Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial. Lancet 2020;395:1268-77: A New Standard for a Rare Disease? Optimizing the Timing of Chemotherapy for Upper Tract Urothelial Carcinoma.
    Singla N; Margulis V;
    Eur Urol; 2021 Jan; 79(1):e28. PubMed ID: 33008662
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort.
    Corsi NJ; Stephens A; Finati M; Malchow T; Morrison C; Davis M; Hares K; Corsi MP; Arora S; Chiarelli G; Cirulli GO; Autorino R; Sood A; Rogers C; Abdollah F
    Urol Oncol; 2024 Jun; 42(6):175.e19-175.e25. PubMed ID: 38522975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) - opening of the peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial.
    Birtle AJ; Lewis R; Johnson M; Hall E;
    BJU Int; 2012 Oct; 110(7):919-21. PubMed ID: 22882350
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding Adjuvant Therapy for Upper Tract Urothelial Carcinoma.
    Berg SA; Galsky MD
    J Clin Oncol; 2024 May; 42(13):1459-1461. PubMed ID: 38359384
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adjuvant chemotherapy in the treatment of urothelial carcinoma of the upper urinary tract].
    Pape L; Richter J; Dunst J
    Strahlenther Onkol; 2020 Sep; 196(9):837-840. PubMed ID: 32561938
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study.
    Vassilakopoulou M; de la Motte Rouge T; Colin P; Ouzzane A; Khayat D; Dimopoulos MA; Papadimitriou CA; Bamias A; Pignot G; Nouhaud FX; Hurel S; Guy L; Bigot P; Roumiguié M; Rouprêt M;
    Cancer; 2011 Dec; 117(24):5500-8. PubMed ID: 21638278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous antegrade infusion of adriamycin as adjuvant therapy for upper tract urothelial malignancies.
    See WA
    Urology; 2000 Aug; 56(2):216-22. PubMed ID: 10925081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
    Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative chemotherapy for upper tract urothelial carcinoma: show me the evidence.
    Pradère B; Califano G; Xylinas E
    Curr Opin Urol; 2021 Jan; 31(1):66-67. PubMed ID: 33196539
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Effectiveness of Adjuvant Chemotherapy after Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
    Laguna MP
    J Urol; 2017 Oct; 198(4):739-740. PubMed ID: 28905781
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tract.
    De Mulder PH; Theodore C; Sella A; Koriakine O; Sternberg CN; Collette L; de Balincourt C
    Ann Oncol; 2000 Nov; 11(11):1391-4. PubMed ID: 11142477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment of Metastatic Upper Tract Urothelial Carcinoma With Vemurafenib: Case Report.
    Ji G; Qian Y
    Clin Genitourin Cancer; 2017 Aug; 15(4):e719-e721. PubMed ID: 28024948
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: Is There Sufficient Evidence?
    Biswas B; Ganguly S; Ghosh J; E P; Dabkara D
    J Clin Oncol; 2017 Jun; 35(18):2095-2096. PubMed ID: 28471709
    [No Abstract]   [Full Text] [Related]  

  • 20. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma.
    Huang YC; Chen MF; Shi CS; Shindel AW; Huang CE; Pang ST; Chuang CK; Chen CS; Chang YH; Lin WY; Ho DR; Chin CC; Kuo YH; Wu CF
    J Urol; 2015 Aug; 194(2):323-9. PubMed ID: 25796114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.